BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 17766259)

  • 1. A methodology for auto-monitoring of internal contamination by 131I in nuclear medicine workers.
    Vidal MV; Dantas AL; Dantas BM
    Radiat Prot Dosimetry; 2007; 125(1-4):483-7. PubMed ID: 17766259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of internal exposure of nuclear medicine staff through in vivo and in vitro bioassay techniques.
    Lucena EA; Rebelo AM; Araújo F; Sousa WO; Dantas AL; Dantas BM; Corbo R
    Radiat Prot Dosimetry; 2007; 127(1-4):465-8. PubMed ID: 17681960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncertainties in determination of 131I activity in thyroid gland.
    Ośko J; Golnik N; Pliszczynski T
    Radiat Prot Dosimetry; 2007; 125(1-4):516-9. PubMed ID: 17309877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IDEAS internal contamination database: a compilation of published internal contamination cases. A tool for the internal dosimetry community.
    Hurtgen C; Andrasi A; Bailey M; Blanchardon E; Berkovski V; Castellani CM; Doerfel H; Jourdain JR; LeGuen B; Malatova I; Marsh J; Puncher M
    Radiat Prot Dosimetry; 2007; 125(1-4):520-2. PubMed ID: 17012307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDA improvement technique for lung counter measurements of uranium workers.
    Pelled O; German U; Pollak G; Tshuva A
    Radiat Prot Dosimetry; 2007; 125(1-4):496-9. PubMed ID: 17355982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of internal radionuclide contamination by mobile laboratories.
    Castagnet X; Amabile JC; Cazoulat A; Lecompte Y; de Carbonnières H; Laroche P
    Radiat Prot Dosimetry; 2007; 125(1-4):469-71. PubMed ID: 17309874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The quantification of uncertainties in internal doses assessed from monitoring measurements.
    Etherington G
    Radiat Prot Dosimetry; 2007; 125(1-4):544-7. PubMed ID: 17237184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of a case of internal contamination with cobalt radioisotopes.
    Vrba T; Malatova I; Jurochova B
    Radiat Prot Dosimetry; 2007; 125(1-4):527-30. PubMed ID: 17309869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of the uncertainty in internal dose calculation for two contamination cases.
    Blanchardon E; Molokanov A; Franck D; Kochetkov O; Panfilov A; Jourdain JR
    Radiat Prot Dosimetry; 2007; 125(1-4):548-52. PubMed ID: 17237182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvements in routine internal monitoring--an overview of the IDEA project.
    Schmitzer C; Fischer H; Andrasi A; Bouvier C; Carlan L; Franck D; Höllriegl V; Li WB; Oeh U; Ritt J; Roth P; Wahl W; Zombori P
    Radiat Prot Dosimetry; 2007; 125(1-4):472-6. PubMed ID: 17553864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure of workers in a mineral processing industry in Brazil.
    Julião LM; Melo DR; Sousa WO; Santos MS; Fernandes PC; Godoy ML
    Radiat Prot Dosimetry; 2007; 125(1-4):513-5. PubMed ID: 17369613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the uncertainty in internal dose estimate resulting from biological stochastic variability of excretion.
    Molokanov A; Blanchardon E
    Radiat Prot Dosimetry; 2007; 125(1-4):561-4. PubMed ID: 17848381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of bioassay methods to improve assessment of incorporated radionuclides.
    Oeh U; Andrasi A; Bouvier-Capely C; De Carlan L; Fischer H; Franck D; Höllriegl V; Li WB; Ritt J; Roth P; Schmitzer Ch; Wahl W; Zombori P
    Radiat Prot Dosimetry; 2007; 125(1-4):444-8. PubMed ID: 17309876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical implications of procedures developed in IDEA project--comparison with traditional methods.
    Andrasi A; Bouvier C; Brandl A; de Carlan L; Fischer H; Franck D; Höllriegl V; Li WB; Oeh U; Ritt J; Roth P; Schlagbauer M; Schmitzer Ch; Wahl W; Zombori P
    Radiat Prot Dosimetry; 2007; 125(1-4):456-9. PubMed ID: 17314089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of voxel phantoms in whole-body counting for the validation of calibration phantoms and the assessment of uncertainties.
    de Carlan L; Roch P; Blanchardon E; Franck D
    Radiat Prot Dosimetry; 2007; 125(1-4):477-82. PubMed ID: 17018545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishing a threshold for 131I bioassay in nuclear medicine personnel.
    Liang Y; Chu RY; Galbraith WK; Macdurmon GW; Sonnad JR
    Health Phys; 2008 Nov; 95(5 Suppl):S175-9. PubMed ID: 18849711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of monitoring for internal exposure by urine bioassay in a biomedical research facility.
    Shoji M; Kondo T; Honoki H; Nakajima T; Muraguchi A; Saito M
    Radiat Prot Dosimetry; 2007; 127(1-4):456-60. PubMed ID: 17956934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Worldwide bioassay data resources for plutonium/americium internal dosimetry studies.
    Miller G; Riddell AE; Filipy R; Bertelli L; Little T; Guilmette R
    Radiat Prot Dosimetry; 2007; 125(1-4):531-7. PubMed ID: 17337740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monte Carlo based voxel phantoms for in vivo internal dosimetry.
    Ros JM; Moraleda M; López MA; Navarro T; Navarro JF
    Radiat Prot Dosimetry; 2007; 125(1-4):161-5. PubMed ID: 17449911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monte Carlo evaluated parameters for internal dosimetry.
    Gualdrini G; Ferrari P
    Radiat Prot Dosimetry; 2007; 125(1-4):157-60. PubMed ID: 17553866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.